Qiagen (QGEN) Shares Outstanding (Weighted Average) (2009 - 2025)
Qiagen's (QGEN) quarterly Shares Outstanding (Weighted Average) came in at $217.2 million in Q4 2025, down 2.43% year-on-year from $222.6 million in Q4 2024, and down 2.43% quarter-over-quarter from $222.6 million in Q4 2024.
Qiagen (QGEN) Shares Outstanding (Weighted Average) (2009 - 2025) Analysis & Trends
Qiagen has disclosed Shares Outstanding (Weighted Average) across 15 years of filings, most recently posting $217.2 million for Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $217.2 million, down 2.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $217.2 million (down 2.43% YoY), and the FY2025 annual result was $217.2 million, down 2.43% from the prior year.
- Shares Outstanding (Weighted Average) came in at $217.2 million for Q4 2025 at Qiagen, down from $222.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $228.3 million in Q1 2021 to a low of $217.2 million in Q4 2025.
- The 5-year median for Shares Outstanding (Weighted Average) is $227.2 million (2022), against an average of $224.7 million.
- Across the five-year window, Shares Outstanding (Weighted Average) declined 0.47% in 2022 and declined 2.43% in 2025, its largest moves.
- Qiagen's Shares Outstanding (Weighted Average) stood at $228.3 million in 2021, then declined by 0.47% to $227.2 million in 2022, then climbed by 0.42% to $228.1 million in 2023, then dropped by 2.42% to $222.6 million in 2024, then dropped by 2.43% to $217.2 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $217.2 million (Q4 2025), $222.6 million (Q4 2024), and $228.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | 82.14 Bn |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 372.00 Mn |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 707.90 Mn |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 79.65 Mn |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 282.00 Mn |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | 168.40 Mn |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 141.50 Mn |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | 153.00 Mn |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 20.29 Mn |
| 10 | Qiagen | 8.54 Bn | 7.44 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 217.22 Mn |
| Dec 31, 2024 | 222.62 Mn |
| Dec 31, 2023 | 228.15 Mn |
| Mar 31, 2022 | 227.20 Mn |
| Mar 31, 2021 | 228.27 Mn |
| Dec 31, 2019 | 226.78 Mn |
| Dec 31, 2018 | 226.64 Mn |
| Dec 31, 2017 | 228.07 Mn |
| Dec 31, 2016 | 234.80 Mn |
| Mar 31, 2014 | 232.86 Mn |
| Mar 31, 2013 | 233.33 Mn |
| Mar 31, 2012 | 234.93 Mn |
| Sep 30, 2011 | 234.04 Mn |
| Mar 31, 2011 | 233.40 Mn |
| Dec 31, 2010 | 3.09 Mn |
| Sep 30, 2010 | 232.77 Mn |
| Dec 31, 2009 | 206.93 Mn |